查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1334257

全外显子组测序的全球市场

Whole Exome Sequencing
出版日期: | 出版商: Global Industry Analysts, Inc. | 英文 194 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

简介目录

到 2030 年，全球全外显子组测序市场将达到 66 亿美元

随着COVID-19后商业环境的变化，全球全外显子组测序市场预计2022年为15亿美元，预计到2030年将达到66亿美元，从2022年到2030年。预计年复合成长率20.1%。系统是本报告分析的细分市场之一，预计年复合成长率21.2%，到分析期结束时将达到 37 亿美元。鑑于大流行后的持续復苏，未来八年套件细分市场的复合年复合成长率修正为 18.2%。

美国市场预计为4.525亿美元，中国预计年复合成长率为18.8%

到 2022 年，美国整个外显子组测序市场预计将达到 4.525 亿美元。中国作为全球第二大经济体，预计到2030年市场规模将达到11亿美元，2022年至2030年分析期间年复合成长率为18.8%。其他值得注意的地域市场包括日本和加拿大，预计从 2022 年到 2030 年，这两个市场将分别增长 18.3% 和 17.2%。在欧洲，德国的年复合成长率预计约为 14.4%。

受访企业示例

  • Agilent Technologies, Inc.
  • Ambry Genetics
  • BGI Europe
  • Eurofins Genomics GmbH
  • GENEWIZ, Inc.
  • Illumina, Inc.
  • Macrogen, Inc.
  • Roche Nimblegen, Inc.
  • Sengenics
  • Thermo Fisher Scientific, Inc.

目录

第1章调查方法

第2章执行摘要

  • 市场概况
  • 主要企业
  • 市场趋势和促进因素
  • 全球市场预测

第3章市场分析

  • 美国
  • 加拿大
  • 日本
  • 中国
  • 欧洲
  • 法国
  • 德国
  • 意大利
  • 英国
  • 其他欧洲国家
  • 亚太地区
  • 世界其他地区

第4章竞争

简介目录
Product Code: MCP15631

What`s New for 2023?

»Special coverage on Russia-Ukraine war; global inflation; easing of "zero-Covid" policy in China and its `bumpy` reopening; supply chain disruptions, global trade tensions; and risk of recession.

»Global competitiveness and key competitor percentage market shares

» Market presence across multiple geographies - Strong/Active/Niche/Trivial

»Online interactive peer-to-peer collaborative bespoke updates

»Access to our digital archives and MarketGlass Research Platform

»Complimentary updates for one year

Looking Ahead to 2023

The global economy is at a critical crossroads with a number of interlocking challenges and crises running in parallel. The uncertainty around how Russia`s war on Ukraine will play out this year and the war`s role in creating global instability means that the trouble on the inflation front is not over yet. Food and fuel inflation will remain a persistent economic problem. Higher retail inflation will impact consumer confidence and spending. As governments combat inflation by raising interest rates, new job creation will slowdown and impact economic activity and growth. Lower capital expenditure is in the offing as companies go slow on investments, held back by inflation worries and weaker demand. With slower growth and high inflation, developed markets seem primed to enter into a recession. Fears of new COVID outbreaks and China's already uncertain post-pandemic path poses a real risk of the world experiencing more acute supply chain pain and manufacturing disruptions this year. Volatile financial markets, growing trade tensions, stricter regulatory environment and pressure to mainstream climate change into economic decisions will compound the complexity of challenges faced. Year 2023 is expected to be tough year for most markets, investors and consumers. Nevertheless, there is always opportunity for businesses and their leaders who can chart a path forward with resilience and adaptability.

Global Whole Exome Sequencing Market to Reach $6.6 Billion by 2030

In the changed post COVID-19 business landscape, the global market for Whole Exome Sequencing estimated at US$1.5 Billion in the year 2022, is projected to reach a revised size of US$6.6 Billion by 2030, growing at aCAGR of 20.1% over the period 2022-2030. Systems, one of the segments analyzed in the report, is projected to record 21.2% CAGR and reach US$3.7 Billion by the end of the analysis period. Taking into account the ongoing post pandemic recovery, growth in the Kits segment is readjusted to a revised 18.2% CAGR for the next 8-year period.

The U.S. Market is Estimated at $452.5 Million, While China is Forecast to Grow at 18.8% CAGR

The Whole Exome Sequencing market in the U.S. is estimated at US$452.5 Million in the year 2022. China, the world`s second largest economy, is forecast to reach a projected market size of US$1.1 Billion by the year 2030 trailing a CAGR of 18.8% over the analysis period 2022 to 2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 18.3% and 17.2% respectively over the 2022-2030 period. Within Europe, Germany is forecast to grow at approximately 14.4% CAGR.

Select Competitors (Total 42 Featured) -

  • Agilent Technologies, Inc.
  • Ambry Genetics
  • BGI Europe
  • Eurofins Genomics GmbH
  • GENEWIZ, Inc.
  • Illumina, Inc.
  • Macrogen, Inc.
  • Roche Nimblegen, Inc.
  • Sengenics
  • Thermo Fisher Scientific, Inc.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • World Market Trajectories
    • Whole Exome Sequencing - Global Key Competitors Percentage Market Share in 2022 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2022 (E)
    • Impact of Covid-19 and a Looming Global Recession
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Recent Past, Current & Future Analysis for Diagnostics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2030 and % CAGR
    • TABLE 2: World 8-Year Perspective for Diagnostics by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2023 & 2030
    • TABLE 3: World Recent Past, Current & Future Analysis for Personalized Medicine by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2030 and % CAGR
    • TABLE 4: World 8-Year Perspective for Personalized Medicine by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2023 & 2030
    • TABLE 5: World Recent Past, Current & Future Analysis for Other Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2030 and % CAGR
    • TABLE 6: World 8-Year Perspective for Other Applications by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2023 & 2030
    • TABLE 7: World Whole Exome Sequencing Market Analysis of Annual Sales in US$ Thousand for Years 2014 through 2030
    • TABLE 8: World Recent Past, Current & Future Analysis for Whole Exome Sequencing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2030 and % CAGR
    • TABLE 9: World 8-Year Perspective for Whole Exome Sequencing by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2023 & 2030
    • TABLE 10: World Recent Past, Current & Future Analysis for Systems by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2030 and % CAGR
    • TABLE 11: World 8-Year Perspective for Systems by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2023 & 2030
    • TABLE 12: World Recent Past, Current & Future Analysis for Kits by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2030 and % CAGR
    • TABLE 13: World 8-Year Perspective for Kits by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2023 & 2030
    • TABLE 14: World Recent Past, Current & Future Analysis for Services by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2030 and % CAGR
    • TABLE 15: World 8-Year Perspective for Services by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2023 & 2030
    • TABLE 16: World Recent Past, Current & Future Analysis for Drug Discovery & Development by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2030 and % CAGR
    • TABLE 17: World 8-Year Perspective for Drug Discovery & Development by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2023 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Whole Exome Sequencing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2023 (E)
    • TABLE 18: USA Recent Past, Current & Future Analysis for Whole Exome Sequencing by Application - Diagnostics, Drug Discovery & Development, Personalized Medicine and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 19: USA 8-Year Perspective for Whole Exome Sequencing by Application - Percentage Breakdown of Value Sales for Diagnostics, Drug Discovery & Development, Personalized Medicine and Other Applications for the Years 2023 & 2030
    • TABLE 20: USA Recent Past, Current & Future Analysis for Whole Exome Sequencing by Offering - Systems, Kits and Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 21: USA 8-Year Perspective for Whole Exome Sequencing by Offering - Percentage Breakdown of Value Sales for Systems, Kits and Services for the Years 2023 & 2030
  • CANADA
    • TABLE 22: Canada Recent Past, Current & Future Analysis for Whole Exome Sequencing by Application - Diagnostics, Drug Discovery & Development, Personalized Medicine and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 23: Canada 8-Year Perspective for Whole Exome Sequencing by Application - Percentage Breakdown of Value Sales for Diagnostics, Drug Discovery & Development, Personalized Medicine and Other Applications for the Years 2023 & 2030
    • TABLE 24: Canada Recent Past, Current & Future Analysis for Whole Exome Sequencing by Offering - Systems, Kits and Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 25: Canada 8-Year Perspective for Whole Exome Sequencing by Offering - Percentage Breakdown of Value Sales for Systems, Kits and Services for the Years 2023 & 2030
  • JAPAN
    • Whole Exome Sequencing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2023 (E)
    • TABLE 26: Japan Recent Past, Current & Future Analysis for Whole Exome Sequencing by Application - Diagnostics, Drug Discovery & Development, Personalized Medicine and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 27: Japan 8-Year Perspective for Whole Exome Sequencing by Application - Percentage Breakdown of Value Sales for Diagnostics, Drug Discovery & Development, Personalized Medicine and Other Applications for the Years 2023 & 2030
    • TABLE 28: Japan Recent Past, Current & Future Analysis for Whole Exome Sequencing by Offering - Systems, Kits and Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 29: Japan 8-Year Perspective for Whole Exome Sequencing by Offering - Percentage Breakdown of Value Sales for Systems, Kits and Services for the Years 2023 & 2030
  • CHINA
    • Whole Exome Sequencing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2023 (E)
    • TABLE 30: China Recent Past, Current & Future Analysis for Whole Exome Sequencing by Application - Diagnostics, Drug Discovery & Development, Personalized Medicine and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 31: China 8-Year Perspective for Whole Exome Sequencing by Application - Percentage Breakdown of Value Sales for Diagnostics, Drug Discovery & Development, Personalized Medicine and Other Applications for the Years 2023 & 2030
    • TABLE 32: China Recent Past, Current & Future Analysis for Whole Exome Sequencing by Offering - Systems, Kits and Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 33: China 8-Year Perspective for Whole Exome Sequencing by Offering - Percentage Breakdown of Value Sales for Systems, Kits and Services for the Years 2023 & 2030
  • EUROPE
    • Whole Exome Sequencing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2023 (E)
    • TABLE 34: Europe Recent Past, Current & Future Analysis for Whole Exome Sequencing by Application - Diagnostics, Drug Discovery & Development, Personalized Medicine and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 35: Europe 8-Year Perspective for Whole Exome Sequencing by Application - Percentage Breakdown of Value Sales for Diagnostics, Drug Discovery & Development, Personalized Medicine and Other Applications for the Years 2023 & 2030
    • TABLE 36: Europe Recent Past, Current & Future Analysis for Whole Exome Sequencing by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2030 and % CAGR
    • TABLE 37: Europe 8-Year Perspective for Whole Exome Sequencing by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK and Rest of Europe Markets for Years 2023 & 2030
    • TABLE 38: Europe Recent Past, Current & Future Analysis for Whole Exome Sequencing by Offering - Systems, Kits and Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 39: Europe 8-Year Perspective for Whole Exome Sequencing by Offering - Percentage Breakdown of Value Sales for Systems, Kits and Services for the Years 2023 & 2030
  • FRANCE
    • Whole Exome Sequencing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2023 (E)
    • TABLE 40: France Recent Past, Current & Future Analysis for Whole Exome Sequencing by Application - Diagnostics, Drug Discovery & Development, Personalized Medicine and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 41: France 8-Year Perspective for Whole Exome Sequencing by Application - Percentage Breakdown of Value Sales for Diagnostics, Drug Discovery & Development, Personalized Medicine and Other Applications for the Years 2023 & 2030
    • TABLE 42: France Recent Past, Current & Future Analysis for Whole Exome Sequencing by Offering - Systems, Kits and Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 43: France 8-Year Perspective for Whole Exome Sequencing by Offering - Percentage Breakdown of Value Sales for Systems, Kits and Services for the Years 2023 & 2030
  • GERMANY
    • Whole Exome Sequencing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2023 (E)
    • TABLE 44: Germany Recent Past, Current & Future Analysis for Whole Exome Sequencing by Application - Diagnostics, Drug Discovery & Development, Personalized Medicine and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 45: Germany 8-Year Perspective for Whole Exome Sequencing by Application - Percentage Breakdown of Value Sales for Diagnostics, Drug Discovery & Development, Personalized Medicine and Other Applications for the Years 2023 & 2030
    • TABLE 46: Germany Recent Past, Current & Future Analysis for Whole Exome Sequencing by Offering - Systems, Kits and Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 47: Germany 8-Year Perspective for Whole Exome Sequencing by Offering - Percentage Breakdown of Value Sales for Systems, Kits and Services for the Years 2023 & 2030
  • ITALY
    • TABLE 48: Italy Recent Past, Current & Future Analysis for Whole Exome Sequencing by Application - Diagnostics, Drug Discovery & Development, Personalized Medicine and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 49: Italy 8-Year Perspective for Whole Exome Sequencing by Application - Percentage Breakdown of Value Sales for Diagnostics, Drug Discovery & Development, Personalized Medicine and Other Applications for the Years 2023 & 2030
    • TABLE 50: Italy Recent Past, Current & Future Analysis for Whole Exome Sequencing by Offering - Systems, Kits and Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 51: Italy 8-Year Perspective for Whole Exome Sequencing by Offering - Percentage Breakdown of Value Sales for Systems, Kits and Services for the Years 2023 & 2030
  • UNITED KINGDOM
    • Whole Exome Sequencing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2023 (E)
    • TABLE 52: UK Recent Past, Current & Future Analysis for Whole Exome Sequencing by Application - Diagnostics, Drug Discovery & Development, Personalized Medicine and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 53: UK 8-Year Perspective for Whole Exome Sequencing by Application - Percentage Breakdown of Value Sales for Diagnostics, Drug Discovery & Development, Personalized Medicine and Other Applications for the Years 2023 & 2030
    • TABLE 54: UK Recent Past, Current & Future Analysis for Whole Exome Sequencing by Offering - Systems, Kits and Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 55: UK 8-Year Perspective for Whole Exome Sequencing by Offering - Percentage Breakdown of Value Sales for Systems, Kits and Services for the Years 2023 & 2030
  • REST OF EUROPE
    • TABLE 56: Rest of Europe Recent Past, Current & Future Analysis for Whole Exome Sequencing by Application - Diagnostics, Drug Discovery & Development, Personalized Medicine and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 57: Rest of Europe 8-Year Perspective for Whole Exome Sequencing by Application - Percentage Breakdown of Value Sales for Diagnostics, Drug Discovery & Development, Personalized Medicine and Other Applications for the Years 2023 & 2030
    • TABLE 58: Rest of Europe Recent Past, Current & Future Analysis for Whole Exome Sequencing by Offering - Systems, Kits and Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 59: Rest of Europe 8-Year Perspective for Whole Exome Sequencing by Offering - Percentage Breakdown of Value Sales for Systems, Kits and Services for the Years 2023 & 2030
  • ASIA-PACIFIC
    • Whole Exome Sequencing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2023 (E)
    • TABLE 60: Asia-Pacific Recent Past, Current & Future Analysis for Whole Exome Sequencing by Application - Diagnostics, Drug Discovery & Development, Personalized Medicine and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 61: Asia-Pacific 8-Year Perspective for Whole Exome Sequencing by Application - Percentage Breakdown of Value Sales for Diagnostics, Drug Discovery & Development, Personalized Medicine and Other Applications for the Years 2023 & 2030
    • TABLE 62: Asia-Pacific Recent Past, Current & Future Analysis for Whole Exome Sequencing by Offering - Systems, Kits and Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 63: Asia-Pacific 8-Year Perspective for Whole Exome Sequencing by Offering - Percentage Breakdown of Value Sales for Systems, Kits and Services for the Years 2023 & 2030
  • REST OF WORLD
    • TABLE 64: Rest of World Recent Past, Current & Future Analysis for Whole Exome Sequencing by Application - Diagnostics, Drug Discovery & Development, Personalized Medicine and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 65: Rest of World 8-Year Perspective for Whole Exome Sequencing by Application - Percentage Breakdown of Value Sales for Diagnostics, Drug Discovery & Development, Personalized Medicine and Other Applications for the Years 2023 & 2030
    • TABLE 66: Rest of World Recent Past, Current & Future Analysis for Whole Exome Sequencing by Offering - Systems, Kits and Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 67: Rest of World 8-Year Perspective for Whole Exome Sequencing by Offering - Percentage Breakdown of Value Sales for Systems, Kits and Services for the Years 2023 & 2030

IV. COMPETITION